Completion of US FDA Inspection at Auroactive Pharma Pvt Ltd

The United States Food and Drug Administration (US FDA) conducted an inspection at Auroactive Pharma Private Limited (a wholly owned subsidiary of Aurobindo Pharma Ltd), which manufactures Active Pharmaceutical Ingredients (API) & Pharmaceutical Formulation Intermediates, situated at Sy Nos 231, 285 to 291, Sancham Village, Ranasthalam Mandal, Srikakulam District, 523 409, Andhra Pradesh, from June 22, 2026, to June 26, 2026.

The inspection concluded with 2 observations and will be responded to within the stipulated time. The Company is committed to maintaining the highest quality manufacturing standards.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1554.95 as compared to the previous close of Rs. 1529.70. The total number of shares traded during the day was 38281 in over 2462 trades.

The stock hit an intraday high of Rs. 1564.70 and intraday low of 1536.40. The net turnover during the day was Rs. 59489314.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals AuroactivePharma USFDA Inspection 2Observations